Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of the National Cancer Institute

• Publication date

  2004-05-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JNCI/DJH120PMID 15126605
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth

  2003cited by this paper
• RNA cleaving '10-23' DNAzymes with enhanced stability and activity.

  2003cited by this paper
• Clinical translation of angiogenesis inhibitors

  2002cited by this paper
• NF1/X represses PDGF A‐chain transcription by interacting with Sp1 and antagonizing Sp1 occupancy of the promoter

  2002cited by this paper
• The Critical Role of Basement Membrane-Independent Laminin γ1 Chain during Axon Regeneration in the CNS

  2002cited by this paper
• c-Jun Regulates Vascular Smooth Muscle Cell Growth and Neointima Formation after Arterial Injury

  2002cited by this paper
• Catalytic Antisense DNA Molecules Targeting Egr-1 Inhibit Neointima Formation following Permanent Ligation of Rat Common Carotid Arteries

  2002cited by this paper
• Antiangiogenesis agents.

  2002cited by this paper
• DNAzymes: cutting a path to a new class of therapeutics.

  2002cited by this paper
• AP-1 in cell proliferation and survival

  2001cited by this paper
• Catalytic Oligodeoxynucleotides Define a Key Regulatory Role for Early Growth Response Factor-1 in the Porcine Model of Coronary In-Stent Restenosis

  2001cited by this paper
• Centenary Nobel Prize in Physiology or Medicine for the cell cycle

  2001cited by this paper
• Anti-angiogenesis: A new potential strategy to inhibit restenosis

  2001cited by this paper
• DNA enzyme targeting TNF-alpha mRNA improves hemodynamic performance in rats with postinfarction heart failure.

  2001cited by this paper
• c-jun cooperates with SV40 T-antigen to sustain MMP-2 expression in immortalized cells.

  2001cited by this paper
• Calculating nucleic acid secondary structure.

  2000cited by this paper
• Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization.

  2000cited by this paper
• The Influence of Arm Length Asymmetry and Base Substitution on the Activity of the 10-23 DNA Enzyme

  2000cited by this paper
• The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest.

  2000cited by this paper
• Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.

  2000cited by this paper
• Overexpression of c-Fos enhances the transcription of human arachidonate 12-lipoxygenase in A431 cells.

  1999cited by this paper
• Control of cell cycle progression by c-Jun is p53 dependent.

  1999cited by this paper
• Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: implications for angiogenesis.

  1999cited by this paper
• Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion.

  1999cited by this paper
• New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury

  1999cited by this paper
• Bioactivity of anti-angiogenic ribozymes targeting Flt-1 and KDR mRNA

  1999cited by this paper
• Broad Antitumor and Antiangiogenic Activities of AG3340, a Potent and Selective MMP Inhibitor Undergoing Advanced Oncology Clinical Trials

  1999cited by this paper
• Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.

  1999cited by this paper
• Correlation of antiangiogenic and antitumor efficacy of N-biphenyl sulfonyl-phenylalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitor.

  1999cited by this paper
• New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury

  1999cited by this paper
• Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.

  1998cited by this paper
• Regeneration in the CNS: optimism mounts.

  1998cited by this paper
• Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination.

  1997cited by this paper
• A general purpose RNA-cleaving DNA enzyme.

  1997cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture.

  1993cited by this paper
• c-Jun is essential for normal mouse development and hepatogenesis

  1993cited by this paper
• c-Jun is essential for normal mouse development and hepatogenesis

  1993cited by this paper
• The jun and fos protein families are both required for cell cycle progression in fibroblasts

  1991cited by this paper
• On finding all suboptimal foldings of an RNA molecule.

  1989cited by this paper
• Anti‐Angiogenesis: New Concept for Therapy of Solid Tumors

  1972cited by this paper

• c-Jun promotes neuroblastoma cell differentiation by inhibiting APC formation via CDC16 and reduces neuroblastoma malignancy

  2025cites this paper
• Jun, an Oncological Foe or Friend?

  2025cites this paper
• DNAzyme Loaded Nano-Niosomes Confer Anti-Cancer Effects in the Human Breast Cancer MCF-7 Cells by Inhibiting Apoptosis, Inflammation, and c-Myc/cyclin D1

  2024cites this paper
• Interplay between CD28 and PD-1 in T cell immunotherapy.

  2024cites this paper
• Substantial antiviral potential of deoxyribozymes fixed on anatase nanoparticles against influenza A viruses in vitro and in vivo.

  2023cites this paper
• A promising nucleic acid therapy drug: DNAzymes and its delivery system

  2023cites this paper
• DNA tetrahedral nanostructures for the biomedical application and spatial orientation of biomolecules

  2023cites this paper
• The m7G Reader NCBP2 Promotes Pancreatic Cancer Progression by Upregulating MAPK/ERK Signaling

  2023cites this paper
• Single-Cell Analysis Reveals Transcriptomic Reprogramming in Aging Cardiovascular Endothelial Cells

  2022cites this paper
• Emerging Role of AP-1 Transcription Factor JunB in Angiogenesis and Vascular Development

  2021cites this paper
• DNAzymes, Novel Therapeutic Agents in Cancer Therapy: A Review of Concepts to Applications

  2021cites this paper
• c-Jun, Foxo3a, and c-Myc Transcription Factors are Key Regulators of ATP-Mediated Angiogenic Responses in Pulmonary Artery Vasa Vasorum Endothelial Cells

  2020cites this paper
• Molecular Features and Metal Ions That Influence 10-23 DNAzyme Activity

  2020cites this paper
• Tetrahedral DNA Nanostructure-Delivered DNAzyme for Gene Silencing to Suppress Cell Growth.

  2019cites this paper
• Deoxyribozymes as Catalytic Nanotherapeutic Agents.

  2019cites this paper
• The role of AP-1 in self-sufficient proliferation and migration of cancer cells and its potential impact on an autocrine/paracrine loop

  2018cites this paper
• UV and Skin: Photocarcinogenesis

  2018cites this paper
• Melanoma protective antitumor immunity activated by catalytic DNA

  2018cites this paper
• Identification of hypoxia-regulated angiogenic genes in colorectal cancer.

  2017cites this paper
• Molecules of somatosensory map plasticity

  2017cites this paper
• Environment and Skin

  2017cites this paper
• Current and future developments in the treatment of virus-induced hypercytokinemia

  2017cites this paper
• Cellular diversity of the somatosensory cortical map plasticity

  2017cites this paper
• A co-delivery nanosystem of chemotherapeutics and DNAzyme overcomes cancer drug resistance and metastasis

  2017cites this paper
• APE1 modulates cellular responses to organophosphate pesticide-induced oxidative damage in non-small cell lung carcinoma A549 cells

  2017cites this paper
• Matrix Metalloproteinases in Bone Resorption, Remodeling, and Repair.

  2017cites this paper
• Molecules of map plasticity in the somatosensory cortex

  2017cites this paper
• DNAzymes Dz13 target the c-jun possess antiviral activity against influenza A viruses.

  2017cites this paper
• Inhibition of intimal thickening after vascular injury with a cocktail of vascular endothelial growth factor and cyclic Arg-Gly-Asp peptide.

  2016cites this paper
• Stimulation of bone regeneration with pigment epithelium-derived factor microparticles: evidence in silico, in vitro and in vivo.

  2016cites this paper
• VEGFR-1 targeted DNAzyme via transcatheter arterial delivery influences tumor vasculature assessed through dynamic contrast-enhanced magnetic resonance imaging.

  2016cites this paper
• xidative stress and inflammation in cerebral cavernous alformation disease pathogenesis : Two sides of the same coin

  2016cites this paper
• Deciphering Post-transcriptional Gene Silencing Pathways Through Genetic Screens

  2016cites this paper
• Selection and antitumor activity of anti-Bcl-2 DNAzymes.

  2016cites this paper
• Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin

  2016cites this paper
• DNAzyme-based biosensors and nanodevices.

  2015cites this paper
• Development, Practice, and Perspectives for DNA Enzyme Systems

  2015cites this paper
• EXPLORING THE GENOME-WIDE IMPACT OF TRANSCRIPTION FACTOR AP-1 IN BREAST CANCER

  2015cites this paper
• Hibiscus sabdariffa Leaf Extract Inhibits Human Prostate Cancer Cell Invasion via Down-Regulation of Akt/NF-κB/MMP-9 Pathway

  2015cites this paper
• C-Jun recruits the NSL complex to regulate its target gene expression by modulating H4K16 acetylation and promoting the release of the repressive NuRD complex

  2015cites this paper
• DNA enzymes as potential therapeutics: towards clinical application of 10-23 DNAzymes

  2015cites this paper
• Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis

  2015cites this paper
• DNAzyme-based therapeutics for cancer treatment.

  2015cites this paper
• Identification and characterization of DNAzymes targeting DNA methyltransferase I for suppressing bladder cancer proliferation.

  2015cites this paper
• Cerebral cavernous malformation (CCM) disease: from monogenic forms to genetic susceptibility factors.

  2015cites this paper
• Development of a protective dermal drug delivery system for therapeutic DNAzymes.

  2015cites this paper
• ERK3 Promotes Endothelial Cell Functions by Upregulating SRC‐3/SP1‐Mediated VEGFR2 Expression

  2014cites this paper
• Roles of PI3K/Akt and c-Jun Signaling Pathways in Human Papillomavirus Type 16 Oncoprotein-Induced HIF-1α, VEGF, and IL-8 Expression and In Vitro Angiogenesis in Non-Small Cell Lung Cancer Cells

  2014cites this paper
• Mechanisms of tumour vascularization in cutaneous malignant melanoma: clinical implications

  2014cites this paper
• AP-1/c-Jun transcription factors: regulation and function in malignant melanoma.

  2014cites this paper
• Regulatory roles of c-jun in H5N1 influenza virus replication and host inflammation.

  2014cites this paper
• Chemosensitization of Solid Tumors by Inhibition of Bcl-xL Expression Using DNAzyme

  2014cites this paper
• Fluorescence Visualization Screening for EBV-LMP1-Targeted DNAzymes

  2014cites this paper
• A novel matrix metalloproteinase-2 inhibitor triazolylmethyl aziridine reduces melanoma cell invasion, angiogenesis and targets ERK1/2 phosphorylation

  2014cites this paper
• Therapeutic potential of siRNA and DNAzymes in cancer

  2014cites this paper
• Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.

  2013cites this paper
• Delivery system for DNAzymes using arginine-modified hydroxyapatite nanoparticles for therapeutic application in a nasopharyngeal carcinoma model

  2013cites this paper
• Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER).

  2013cites this paper
• GILZ Overexpression Inhibits Endothelial Cell Adhesive Function through Regulation of NF-κB and MAPK Activity

  2013cites this paper
• Insights into Roles of Immediate-Early Genes in Angiogenesis

  2013cites this paper
• Therapeutic Evaluation of Epstein-Barr Virus-encoded Latent Membrane Protein-1 Targeted DNAzyme for Treating of Nasopharyngeal Carcinomas

  2013cites this paper
• current as B and MAPK Activity κ of NF-Cell Adhesive Function through Regulation GILZ Overexpression Inhibits Endothelial

  2013cites this paper
• SUMO1 regulates endothelial function by modulating the overall signals in favor of angiogenesis and homeostatic responses.

  2013cites this paper
• Use of DNAzymes for cancer research and therapy

  2012cites this paper
• Potential use of nucleic acid-based agents in the sensitization of nasopharyngeal carcinoma to radiotherapy.

  2012cites this paper
• Destroying c-jun Messenger: New Insights into Biological Mechanisms of DNAzyme Function

  2012cites this paper
• DNAzyme Targeting c-jun Suppresses Skin Cancer Growth

  2012cites this paper
• Intracoronary delivery of DNAzymes targeting human EGR‐1 reduces infarct size following myocardial ischaemia reperfusion

  2012cites this paper
• ETS‐1/RhoC signaling regulates the transcription factor c‐Jun in melanoma

  2012cites this paper
• Gene profiling v-Src transformation in primary avian cells and the identification of the novel Src-responsive gene DAPK1 as a mediator of apoptosis in Src-transformed cells with repressed AP-1 activity

  2012cites this paper
• Induction of Caspase-2 Activation by a DNA Enzyme Evokes Tumor Cell Apoptosis

  2012cites this paper
• Deoxyribozymes and bioinformatics: complementary tools to investigate axon regeneration

  2011cites this paper
• A Novel Peptide Derived from Human Apolipoprotein E Is an Inhibitor of Tumor Growth and Ocular Angiogenesis

  2011cites this paper
• The Transcription Factor AP-1 in Squamous Cell Carcinogenesis: Lessons from Mouse Models of Skin Carcinogenesis

  2011cites this paper
• Deoxyribozymes: New Therapeutics to Treat Central Nervous System Disorders

  2011cites this paper
• Dz13: c‐Jun Downregulation and Tumour Cell Death

  2011cites this paper
• Emerging therapeutic approaches in the management of retinal angiogenesis and edema

  2011cites this paper
• Members of the CREB/ATF and AP1 family of transcription factors are involved in the regulation of SOX18 gene expression

  2011cites this paper
• Benzyl Isothiocyanate Suppresses Pancreatic Tumor Angiogenesis and Invasion by Inhibiting HIF-α/VEGF/Rho-GTPases: Pivotal Role of STAT-3

  2011cites this paper
• Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway.

  2010cites this paper
• A nanoparticulate system that enhances the efficacy of the tumoricide Dz13 when administered proximal to the lesion site.

  2010cites this paper
• Dz13 Induces a Cytotoxic Stress Response with Upregulation of E2F1 in Tumor Cells Metastasizing to or from Bone

  2010cites this paper
• Emerging roles of ATF2 and the dynamic AP1 network in cancer

  2010cites this paper
• Dz13, a c-jun DNAzyme, Is a Potent Inducer of Caspase-2 Activation

  2010cites this paper
• Sequence-Related Off-Target Effect of Dz13 Against Human Tumor Cells and Safety in Adult and Fetal Mice Following Systemic Administration

  2010influential citation
• Direct anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours

  2010influential citation
• Hypoxic/Normoxic Preconditioning Increases Endothelial Differentiation Potential of Human Bone Marrow CD133+ Cells

  2010cites this paper
• Biologically inspired synthetic enzymes made from DNA.

  2009cites this paper
• Inhibition of cell proliferation, migration and invasion by DNAzyme targeting MMP-9 in A549 cells.

  2009cites this paper
• Cancer, chitosan nanoparticles and catalytic nucleic acids

  2009cites this paper
• DNAzymes and their therapeutic possibilities

  2009cites this paper
• Andrographolide could inhibit human colorectal carcinoma Lovo cells migration and invasion via down-regulation of MMP-7 expression.

  2009cites this paper
• Cancer, chitosan nanoparticles and catalytic nucleic acids.

  2009cites this paper
• Biotechnological Approaches for the Treatment of Inflammatory Diseases

  2009cites this paper
• Identification of integrins α6 and β7 as c‐Jun‐ and transformation‐relevant genes in highly invasive fibrosarcoma cells

  2009cites this paper
• DNAzyme delivery systems: getting past first base.

  2009cites this paper
• c-Jun Regulates Shear- and Injury-inducible Egr-1 Expression, Vein Graft Stenosis after Autologous End-to-Side Transplantation in Rabbits, and Intimal Hyperplasia in Human Saphenous Veins*

  2009cites this paper
• Osteosarcomatreatment vs. gene therapy

  2009cites this paper
• Characterization of an RNA-cleaving deoxyribozyme with optimal activity at pH 5.

  2009cites this paper
• Effect of DNAzymes targeting Akt1 on cell proliferation and apoptosis in nasopharyngeal carcinoma

  2009cites this paper